HIGHFDA DRUG
Quallent Pharmaceuticals Recalls Duloxetine Capsules Over Impurity Risk
Quallent Pharmaceuticals recalled 3,591 bottles of Duloxetine Delayed-Release Capsules on August 8, 2025. The recall stems from CGMP deviations regarding an impurity exceeding safety limits. Consumers should stop using the product immediately and contact their healthcare provider.
DULOXETINE
CGMP deviations: